首页> 外国专利> BACILLE CALMETTE-GUERIN (BCG)-BASED ANTI-ATHEROMA VACCINE AND METHODS OF USE THEREOF

BACILLE CALMETTE-GUERIN (BCG)-BASED ANTI-ATHEROMA VACCINE AND METHODS OF USE THEREOF

机译：基于巴卡利特-姜黄素（BCG）的抗星形胶质瘤疫苗及其使用方法

页面导航

摘要
著录项
相似文献

摘要

The invention relates to a recombinant Mycobacterium bovis which expresses at least one Chlamydophila pneumoniae antigen.

机译：本发明涉及一种重组牛分枝杆菌，它表达至少一种肺炎衣原体抗原。

著录项

公开/公告号US2009252765A1

专利类型
公开/公告日2009-10-08

原文格式PDF
申请/专利权人 KATALIN BURIAN;VALERIA ENDRESZ;VIJAY KAKKAR;XINJIE LU;ANDRAS MICZAK;
展开▼

申请/专利号US20080122454
发明设计人 KATALIN BURIAN;VALERIA ENDRESZ;VIJAY KAKKAR;XINJIE LU;ANDRAS MICZAK;
展开▼

申请日2008-05-16
分类号A61K39/04;C12N1/21;C12N15/63;A61K39/118;
国家 US
入库时间 2022-08-21 19:34:00

相似文献

专利
外文文献
中文文献

1. Enhancement of vitamin A combined vitamin D supplementation on immune response to Bacille Calmette-Guérin vaccine revaccinated in Chinese infants [J] . Ying Zheng, Xue-Gang Li, Qiu-Zhen Wang, 亚太热带医药杂志（英文版） . 2014,第002期

2. The influence of neonatal Bacille Calmette-Guerin (BCG) immunisation on heterologous vaccine responses in infants [J] . Zimmermann Petra, Donath Susan, Perrett Kirsten P., Vaccine . 2019,第28期

3. Poly(I:C)-Encapsulating Nanoparticles Enhance Innate Immune Responses to the Tuberculosis Vaccine Bacille Calmette-Guerin (BCG) via Synergistic Activation of Innate Immune Receptors [J] . Speth Martin T., Repnik Urska, Mueller Elisabeth, Molecular pharmaceutics . 2017,第11期

4. A randomized clinical trial in adults and newborns in South Africa to compare the safety and immunogenicity of bacille Calmette-Guerin (BCG) vaccine administration via a disposable-syringe jet injector to conventional technique with needle and syringe [J] . Gedenhuys Hennie D., Mearns Helen, Foster Jennifer, Vaccine . 2015,第37期

5. Shapelet Feature Learning Method of BCG Signal Based on ESOINN [C] . Zimin Wang, Yumeng Wang, Yuhong Meng, International Conference on Intelligent Control and Information Processing . 2019

6. Development and pre-clinical evaluation of a BCG-MUC1-based novel breast cancer vaccine. [D] . Chung, Maureen Angela. 2001

7. Protective immunity elicited by recombinant bacille Calmette-Guerin (BCG) expressing outer surface protein A (OspA) lipoprotein: a candidate Lyme disease vaccine [O] . 1993

8. Effects of exposure to environmental mycobacteria on immunity conferred by bacille calmette-guerin (BCG) vaccine [O] . HO PEIYING 2007

1. Managing Recalcitrant Warts: Facts about Bacillus Calmette-Guerin (BCG), Mycobacterium Indicus Pranii (Mw Vaccine), and Purified Protein Derivative (PPD) as Immunotherapy [J] . Nabeel K. Al Hamzawi ,Mais H. Abdallah . 化妆品、皮肤病及应用期刊（英文） . 2018,第4期

2. Repeated inoculations of Mycobacterium bovis Bacille Calmette-Gu#233;rin (BCG) are needed to induce a strong humoral immune response against antigens expressed by the bacteria [J] . Monique C. da Silva ,Elena B. Lasunskaia ,Wilmar Dias da Silva . 免疫学期刊（英文） . 2013,第3期

3. Comparative Study on the Immunogenicity between Recombinant MS-Sj26GST Vaccine and Recombinant BCG-Sj26GST Vaccine in Schistosoma japonicum [J] . 戴五星 ,高红 ,黄海浪 . 华中科技大学学报（医学）（英德文版） . 2003,第003期

4. Code Clone Detection Method Based on the Combination of Tree-Based and Token-Based Methods [J] . Ryota Ami ,Hirohide Haga . 软件工程与应用（英文） . 2017,第13期

5. 基于GSH响应的超高载药纳米载体及其抗脑胶质瘤研究 [C] . 辛洪亮 ,江艳 ,徐剑培 . 2017中国生物材料大会 . 2017

6. 90K/MaC-2 BP在人脑胶质星形细胞瘤中的表达以及90K/Mac002 BP负载的树突状细胞疫苗抗胶质瘤的实验研究 [A] . 陈鑫 . 2012